Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 30, 2017
Comparison of 1 mg versus 2 mg Dexamethasone Suppression Test in Patients with Obesity
Sandrine Andrea Urwyler, Nina Cupa, Mirjam Christ-Crain
European Journal of Endocrinology
|
September 25, 2014
Copeptin concentrations during psychological stress: the PsyCo study
Judith Siegenthaler, Carla Walti, Sandrine Andrea Urwyler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals
Sandrine Andrea Urwyler, Philipp Schuetz, Fahim Ebrahimi, et al.
Endocrine Connections
|
July 23, 2020
The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome
Milica Popovic, Fahim Ebrahimi, Sandrine Andrea Urwyler, et al.
Pituitary
|
June 20, 2022
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study
Cihan Atila, Sophie Monnerat, Sandrine Andrea Urwyler, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 11, 2020
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese Individuals
Sandrine Andrea Urwyler, Fahim Ebrahimi, Thilo Burkard, et al.
Scientific Reports
|
April 13, 2021
Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
Fahim Ebrahimi, Sandrine Andrea Urwyler, Matthias Johannes Betz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2016
Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome
Sandrine Andrea Urwyler, Katharina Timper, Wiebke Fenske, et al.
Lancet (London, England)
|
January 23, 2015
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
Claudine Angela Blum, Nicole Nigro, Matthias Briel, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
September 30, 2017
Comparison of 1 mg versus 2 mg Dexamethasone Suppression Test in Patients with Obesity
Sandrine Andrea Urwyler, Nina Cupa, Mirjam Christ-Crain
European Journal of Endocrinology
|
September 25, 2014
Copeptin concentrations during psychological stress: the PsyCo study
Judith Siegenthaler, Carla Walti, Sandrine Andrea Urwyler, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 22, 2017
Interleukin-1 Antagonism Decreases Cortisol Levels in Obese Individuals
Sandrine Andrea Urwyler, Philipp Schuetz, Fahim Ebrahimi, et al.
Endocrine Connections
|
July 23, 2020
The role of IL-1 in the regulation of copeptin in patients with metabolic syndrome
Milica Popovic, Fahim Ebrahimi, Sandrine Andrea Urwyler, et al.
Pituitary
|
June 20, 2022
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study
Cihan Atila, Sophie Monnerat, Sandrine Andrea Urwyler, et al.
Hypertension (Dallas, Tex. : 1979)
|
April 11, 2020
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese Individuals
Sandrine Andrea Urwyler, Fahim Ebrahimi, Thilo Burkard, et al.
Scientific Reports
|
April 13, 2021
Effects of interleukin-1 antagonism and corticosteroids on fibroblast growth factor-21 in patients with metabolic syndrome
Fahim Ebrahimi, Sandrine Andrea Urwyler, Matthias Johannes Betz, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 12, 2016
Plasma Apelin Concentrations in Patients With Polyuria-Polydipsia Syndrome
Sandrine Andrea Urwyler, Katharina Timper, Wiebke Fenske, et al.
Lancet (London, England)
|
January 23, 2015
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
Claudine Angela Blum, Nicole Nigro, Matthias Briel, et al.
Page
of 1